UPDATE 1-Xeris Pharma's low blood sugar treatment wins FDA approval
September 10, 2019 at 11:58 AM EDT
The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon pen that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday.